Have we found the cause of myeloma? Not really!

A report this week issued by Yale News announced “Yale researchers discover underlying cause of myeloma,” citing an article published today in the New England Journal of Medicine entitled, “Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma.” This is an article about what triggers the development of MGUS and myeloma in patients with a rare metabolic disease called Gaucher’s disease. The article is thus about how myeloma may be caused in a rare and unusual circumstance – not the average case of myeloma.

To collaborate, or not to collaborate, that is the question

The successes achieved by the IMF’s International Myeloma Working Group (IMWG) are due, in large part, to collaboration. Bringing myeloma researchers together to produce consensus guidelines and to brainstorm about new research ideas, such as the Black Swan Research Initiative® – the IMF’s “Myeloma Moonshot” – has produced significant breakthroughs, advanced understanding and improved patient outcomes.

Sugar and spice: the hilarious and serious about healthy eating

Two new books illustrate both the obsessions and confusion about food. In her book, “I’ll Have What She’s Having: My Adventures in Celebrity Dieting,” Rebecca Harrington describes her adventures in celebrity dieting as she actually tries the diets of celebrities from Liz Taylor to Gwyneth Paltrow to Beyoncé and more. Robert H. Lustig, MD in contrast provides a very scientific and comprehensive review of the dangers of sugar and processed foods in Fat Chance: Beating the Odds against Sugar, Processed Food, Obesity and Disease.

The Black Swan Research Initiative® Is the “Myeloma Moonshot”

Vice President Joe Biden’s cancer “moonshot” has been very much in the news since it was made widely public in President Barack Obama’s State of the Union speech earlier this month. Most commentary has been positive – who does not want more money to go for cancer research? Apparently, the National Cancer Institute’s budget will be increased by $260.5 million to a total of $5.21 billion in the recently approved fiscal 2016 budget.

Myeloma Forecast for 2016: What’s exciting, what’s real…and who do you trust?

As we start off 2016, there is excitement in the air. Three new drug approvals, the Black Swan Research Initiative® is moving strongly into cure trials; it seems that we have myeloma on the run! Yet the reality is that we all know friends, support group members, patients who are not doing well, whose lives are threatened by myeloma despite all that is new and wonderful.

Pages